Literature DB >> 28940111

Hyperuricemia is Associated with Increased Apo AI Fractional Catabolic Rates and Dysfunctional HDL in New Zealand Rabbits.

Miriam Martínez-Ramírez1, Cristóbal Flores-Castillo1, L Gabriela Sánchez-Lozada2, Rocío Bautista-Pérez1, Elizabeth Carreón-Torres1, José Manuel Fragoso1, José Manuel Rodriguez-Pérez1, Fernando E García-Arroyo2, Victoria López-Olmos1, María Luna-Luna1, Gilberto Vargas-Alarcón1, Martha Franco2, Oscar Pérez-Méndez3.   

Abstract

The potential cause-effect relationship between uric acid plasma concentrations and HDL functionality remains elusive. Therefore, this study aimed to explore the effect of oxonic acid (OA)-induced hyperuricemia on the HDL size distribution, lipid content of HDL subclasses, and apo AI turnover, as well as HDL functionality in New Zealand white rabbits. Experimental animals received OA 750 mg/kg/day by oral gavage during 21 days. The HDL-apo AI fractional catabolic rate (FCR) was determined by exogenous labeling with 125I, and HDL subclasses were determined by sequential ultracentrifugation and PAGE. Paraoxonase-1 activity (PON-1) and the effect of HDL on relaxation of aorta rings in vitro were determined as an indication of HDL functionality. Oxonic acid induced a sixfold increase of uricemia (0.84 ± 0.06 vs. 5.24 ± 0.12 mg/dL, P < 0.001), and significant decreases of triglycerides and phospholipids of HDL subclasses, whereas HDL size distribution and HDL-cholesterol remained unchanged. In addition, HDL-apo AI FCR was significantly higher in hyperuricemic rabbits than in the control group (0.03697 ± 0.0038 vs. 0.02605 ± 0.0017 h-1 respectively, P < 0.05). Such structural and metabolic changes were associated with lower levels of PON-1 activities and deleterious effects of HDL particles on endothelium-mediated vasodilation. In conclusion, hyperuricemia is associated with structural and metabolic modifications of HDL that result in impaired functionality of these lipoproteins. Our data strongly suggest that uric acid per se exerts deleterious effects on HDL that contribute to increase the risk of atherosclerosis.

Entities:  

Keywords:  Coronary heart disease; Lipoprotein metabolism; Renal failure; Risk factors; Uricemia

Mesh:

Substances:

Year:  2017        PMID: 28940111     DOI: 10.1007/s11745-017-4301-y

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  42 in total

1.  Clearance of postprandial and lipolytically modified human HDL in rabbits and rats.

Authors:  G F Lewis; B Lamarche; K D Uffelman; A C Heatherington; M A Honig; L W Szeto; P H Barrett
Journal:  J Lipid Res       Date:  1997-09       Impact factor: 5.922

2.  Uremia alters HDL composition and function.

Authors:  Michael Holzer; Ruth Birner-Gruenberger; Tatjana Stojakovic; Dalia El-Gamal; Veronika Binder; Christian Wadsack; Akos Heinemann; Gunther Marsche
Journal:  J Am Soc Nephrol       Date:  2011-07-29       Impact factor: 10.121

3.  Uric acid and prognosis in angiography-proven coronary artery disease.

Authors:  Gjin Ndrepepa; Siegmund Braun; Lamin King; Massimiliano Fusaro; Tomohisa Tada; Salvatore Cassese; Martin Hadamitzky; Hans-Ullrich Haase; Albert Schömig; Adnan Kastrati
Journal:  Eur J Clin Invest       Date:  2012-12-28       Impact factor: 4.686

4.  Effect of the treatment with allopurinol on the endothelial function in patients with hyperuricemia.

Authors:  Gabriela Meléndez-Ramírez; Oscar Pérez-Méndez; Cristhel López-Osorio; Jorge Kuri-Alfaro; Nilda Espinola-Zavaleta
Journal:  Endocr Res       Date:  2011-10-06       Impact factor: 1.720

5.  Uric acid concentration as a risk marker for blood pressure progression and incident hypertension: a Chinese cohort study.

Authors:  Tsan Yang; Chi-Hong Chu; Chyi-Huey Bai; San-Lin You; Yu-Ching Chou; Lee-Ching Hwang; Kuo-Liong Chien; Ta-Chen Su; Chin-Hsiao Tseng; Chien-An Sun
Journal:  Metabolism       Date:  2012-05-30       Impact factor: 8.694

6.  The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients.

Authors:  Kyung-Hyun Cho; Sun-Hyun Park; Jeong Euy Park; Young Ok Kim; Inho Choi; Jong-Joo Kim; Jae-Ryong Kim
Journal:  Clin Biochem       Date:  2007-10-22       Impact factor: 3.281

7.  Association of uric acid with mortality in patients with stable coronary artery disease.

Authors:  Gjin Ndrepepa; Siegmund Braun; Lamin King; Martin Hadamitzky; Hans-Ullrich Haase; Katrin Anette Birkmeier; Albert Schömig; Adnan Kastrati
Journal:  Metabolism       Date:  2012-06-27       Impact factor: 8.694

Review 8.  Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure.

Authors:  Corinna Bergamini; Mariantonietta Cicoira; Andrea Rossi; Corrado Vassanelli
Journal:  Eur J Heart Fail       Date:  2009-04-04       Impact factor: 15.534

9.  The Establishment and Characteristics of Rat Model of Atherosclerosis Induced by Hyperuricemia.

Authors:  Zhen Liu; Tong Chen; Haitao Niu; Wei Ren; Xinde Li; Lingling Cui; Changgui Li
Journal:  Stem Cells Int       Date:  2015-12-21       Impact factor: 5.443

10.  Hypoxanthine induces cholesterol accumulation and incites atherosclerosis in apolipoprotein E-deficient mice and cells.

Authors:  Hye-Myung Ryu; You-Jin Kim; Eun-Joo Oh; Se-Hyun Oh; Ji-Young Choi; Jang-Hee Cho; Chan-Duck Kim; Sun-Hee Park; Yong-Lim Kim
Journal:  J Cell Mol Med       Date:  2016-07-11       Impact factor: 5.310

View more
  3 in total

1.  Repetitions of Strenuous Exercise Consistently Increase Paraoxonase 1 Concentration and Activity in Plasma of Average-Trained Men.

Authors:  Aneta Otocka-Kmiecik; Monika Orłowska-Majdak; Robert Stawski; Urszula Szkudlarek; Piotr Kosielski; Gianluca Padula; Szymon Gałczyński; Dariusz Nowak
Journal:  Oxid Med Cell Longev       Date:  2021-12-07       Impact factor: 6.543

2.  Association of hyperuricemia with apolipoprotein AI and atherogenic index of plasma in healthy Chinese people: a cross-sectional study.

Authors:  Yan Duan; Xiaona Chang; Xiaoyu Ding; Yu An; Guang Wang; Jia Liu
Journal:  BMC Cardiovasc Disord       Date:  2022-08-15       Impact factor: 2.174

Review 3.  Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease.

Authors:  Diego Estrada-Luna; María Araceli Ortiz-Rodriguez; Lizett Medina-Briseño; Elizabeth Carreón-Torres; Jeannett Alejandra Izquierdo-Vega; Ashutosh Sharma; Juan Carlos Cancino-Díaz; Oscar Pérez-Méndez; Helen Belefant-Miller; Gabriel Betanzos-Cabrera
Journal:  Molecules       Date:  2018-10-23       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.